Pharming Group PHAR
$11.54 −$0.63 (-5.18%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $11.54 0.00%
Open$11.85
Prev close$12.17
Day range$11.30 – $11.97
Volume10.5K
Market cap$816.78M
P/E (TTM)35.0
Dividend yield–
PHAR Stock News
Headlines matching Pharming Group or the PHAR ticker, most recent first.
- CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $38
- H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37
- CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Raises Target Price to $38 Positive
- EXTRAWELL PHAR: FORM OF PROXY FOR USE BY SHAREHOLDERS AT THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, 28 AUGUST 2026 AT 11:00 A.M.
- CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37
- Oppenheimer Maintains Pharming Group(PHAR.US) With Buy Rating, Cuts Target Price to $40 Negative
- CCORF Initiates Pharming Group(PHAR.US) With Buy Rating, Announces Target Price $37
- Oppenheimer Maintains Pharming Group(PHAR.US) With Buy Rating, Cuts Target Price to $41 Negative
- Oppenheimer Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $42
- H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37
- EXTRAWELL PHAR: FORM OF PROXY FOR SPECIAL GENERAL MEETING TO BE HELD ON MONDAY, 30 NOVEMBER 2026 AT 10:00 A.M.
- CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Raises Target Price to $41 Positive
- H.C. Wainwright Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $37
- CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $38
- CCORF Maintains Pharming Group(PHAR.US) With Buy Rating, Maintains Target Price $38
No comments yet — be the first to weigh in on PHAR.
Sign in to join the discussion.